Financial insights of PCRX

MyFinsight

For the quarter ending 2025-09-30, PCRX made $179,516,000 in revenue. $5,432,000 in net income. Net profit margin of 3.03%.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total revenues	179,516,000	181,099,000	168,923,000	177,185,000
Cost of goods sold	34,278,000	40,866,000	34,306,000	43,651,000
Research and development	25,966,000	28,200,000	25,342,000	21,067,500
Selling, general and administrative	91,797,000	88,578,000	86,776,000	75,820,000
Amortization of acquired intangible assets	14,322,000	14,322,000	14,322,000	14,322,000
Goodwill impairment	0	-	-	0
Contingent consideration charges (gains), acquisition-related expenses, restructuring and other	6,791,000	634,000	6,187,000	1,925,500
Total operating expenses	173,154,000	172,600,000	166,933,000	158,227,000
Income (loss) from operations	6,362,000	8,499,000	1,990,000	18,958,000
Interest income	8,534,000	5,008,000	6,895,000	4,729,000
Interest expense	4,279,000	4,695,000	4,580,000	3,998,000
(loss) gain on early extinguishment of debt	-983,000	0	-	0
Other, net	-110,000	-10,739,000	4,401,000	-106,000
Total other income (expense), net	3,162,000	-10,426,000	6,716,000	625,000
Income (loss) before income taxes	9,524,000	-1,927,000	8,706,000	19,583,000
Income tax expense	4,092,000	2,920,000	3,894,000	7,073,000
Net income (loss)	5,432,000	-4,847,000	4,812,000	12,510,000

Basic (in shares)	44,038,000	45,459,000	46,275,000	-23,031,500
Basic net income (loss) per common share (in dollars per share)	0.12	-0.11	0.1	0.275
Diluted (in shares)	44,459,000	45,459,000	46,526,000	-25,214,000
Diluted net income (loss) per common share (in dollars per share)	0.12	-0.11	0.1	0.285